Search Results - "Wu, Mengfen J."

Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas by Hill, LaQuisa C., Rouce, Rayne H., Wu, Mengfen J., Wang, Tao, Ma, Royce, Zhang, Huimin, Mehta, Birju, Lapteva, Natalia, Mei, Zhuyong, Smith, Tyler S., Yang, Lina, Srinivasan, Madhuwanti, Burkhardt, Phillip M., Ramos, Carlos A., Lulla, Premal, Arredondo, Martha, Grilley, Bambi, Heslop, Helen E., Brenner, Malcolm K., Mamonkin, Maksim

“…•Autologous CD5 CAR T cells induce clinical responses in r/r mature TCLs.•CD5 CAR T cells were associated with low-grade cytokine release syndrome and…”
Get full text

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects by Vasileiou, Spyridoula, Lulla, Premal D, Tzannou, Ifigeneia, Watanabe, Ayumi, Kuvalekar, Manik, Callejas, Wendy L, Bilgi, Mrinalini, Wang, Tao, Wu, Mengfen J, Kamble, Rammurti, Ramos, Carlos A, Rouce, Rayne H, Zeng, Zihua, Gee, Adrian P, Grilley, Bambi J, Vera, Juan F, Bollard, Catherine M, Brenner, Malcolm K, Heslop, Helen E, Rooney, Cliona M, Leen, Ann M, Carrum, George

“…Patients with relapsed lymphomas often fail salvage therapies including high-dose chemotherapy and mono-antigen-specific T-cell therapies, highlighting the…”
Get full text